Vı́ctor J. Yuste

2.6k total citations
58 papers, 2.1k citations indexed

About

Vı́ctor J. Yuste is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Vı́ctor J. Yuste has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Oncology. Recurrent topics in Vı́ctor J. Yuste's work include Cell death mechanisms and regulation (36 papers), RNA Interference and Gene Delivery (11 papers) and Autophagy in Disease and Therapy (10 papers). Vı́ctor J. Yuste is often cited by papers focused on Cell death mechanisms and regulation (36 papers), RNA Interference and Gene Delivery (11 papers) and Autophagy in Disease and Therapy (10 papers). Vı́ctor J. Yuste collaborates with scholars based in Spain, France and United States. Vı́ctor J. Yuste's co-authors include Santos A. Susín, Joan X. Comella, Rana S. Moubarak, Jacint Boix, Cédric Artus, José R. Bayascas, Núria Llecha, Peter A. Greer, Josiane Ménissier‐de Murcia and Carme Solé and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Neuroscience.

In The Last Decade

Vı́ctor J. Yuste

56 papers receiving 2.1k citations

Peers

Vı́ctor J. Yuste
Bret M. Evers United States
Simone Kühnle Germany
Salih Şanlıoğlu Türkiye
Sharon Frase United States
Annette Bakker United States
Theodoros I. Roumeliotis United Kingdom
Gabriel Ichim France
Annick You-Ten Canada
Iva Klevernic United Kingdom
Sridar V. Chittur United States
Bret M. Evers United States
Vı́ctor J. Yuste
Citations per year, relative to Vı́ctor J. Yuste Vı́ctor J. Yuste (= 1×) peers Bret M. Evers

Countries citing papers authored by Vı́ctor J. Yuste

Since Specialization
Citations

This map shows the geographic impact of Vı́ctor J. Yuste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vı́ctor J. Yuste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vı́ctor J. Yuste more than expected).

Fields of papers citing papers by Vı́ctor J. Yuste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vı́ctor J. Yuste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vı́ctor J. Yuste. The network helps show where Vı́ctor J. Yuste may publish in the future.

Co-authorship network of co-authors of Vı́ctor J. Yuste

This figure shows the co-authorship network connecting the top 25 collaborators of Vı́ctor J. Yuste. A scholar is included among the top collaborators of Vı́ctor J. Yuste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vı́ctor J. Yuste. Vı́ctor J. Yuste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruna, Jordi, et al.. (2025). Reaching the point-of-no-return: The cornerstone of glioblastoma treatment?. Neuro-Oncology Advances. 7(1). vdaf174–vdaf174.
2.
Torres‐Espín, Abel, Núria Bonet, Ferrán Casals, et al.. (2022). A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice. Annals of Clinical and Translational Neurology. 9(12). 1985–1998. 14 indexed citations
3.
Arús, Carles, et al.. (2021). Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells. International Journal of Molecular Sciences. 22(7). 3453–3453. 10 indexed citations
4.
Torres‐Espín, Abel, et al.. (2020). Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response. Neuro-Oncology. 23(1). 88–99. 40 indexed citations
5.
Yang, Shaobin, Lydia Giménez‐Llort, Marı́a Antonia Baltrons, et al.. (2018). Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides. Frontiers in Aging Neuroscience. 9. 435–435. 35 indexed citations
6.
Simó, Marta, Xavier Navarro, Vı́ctor J. Yuste, & Jordi Bruna. (2018). Autonomic nervous system and cancer. Clinical Autonomic Research. 28(3). 301–314. 21 indexed citations
7.
Yuste, Vı́ctor J., et al.. (2015). Autophagy exacerbates caspase-dependent apoptotic cell death after short times of starvation. Biochemical Pharmacology. 98(4). 573–586. 16 indexed citations
8.
Gozzelino, Raffaella, Koen M.O. Galenkamp, Stéphanie Reix, et al.. (2013). TNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway. Cell Death and Disease. 4(2). e493–e493. 61 indexed citations
9.
Gozzelino, Raffaella, María Sánchez‐Osuna, Carme Solé, et al.. (2013). NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(5). 1085–1095. 11 indexed citations
10.
Gabernet, Gisela, et al.. (2012). Apoptotic DNA Degradation into Oligonucleosomal Fragments, but Not Apoptotic Nuclear Morphology, Relies on a Cytosolic Pool of DFF40/CAD Endonuclease. Journal of Biological Chemistry. 287(10). 7766–7779. 27 indexed citations
11.
Moubarak, Rana S., Carme Solé, Marta Pascual, et al.. (2010). The Death Receptor Antagonist FLIP-L Interacts with Trk and Is Necessary for Neurite Outgrowth Induced by Neurotrophins. Journal of Neuroscience. 30(17). 6094–6105. 13 indexed citations
12.
Pérez‐Galán, Patricia, Patricia Galán‐Malo, Vı́ctor J. Yuste, et al.. (2010). Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells. Biochemical Pharmacology. 79(12). 1746–1758. 26 indexed citations
13.
Barbier, Sandrine, Laurent Châtre, Morgane Le Bras, et al.. (2009). Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton. Haematologica. 94(4). 507–517. 21 indexed citations
14.
Ribas, Judit, et al.. (2008). 7-Bromoindirubin-3′-oxime uncovers a serine protease-mediated paradigm of necrotic cell death. Biochemical Pharmacology. 76(1). 39–52. 21 indexed citations
15.
Moubarak, Rana S., Vı́ctor J. Yuste, Cédric Artus, et al.. (2007). Sequential Activation of Poly(ADP-Ribose) Polymerase 1, Calpains, and Bax Is Essential in Apoptosis-Inducing Factor-Mediated Programmed Necrosis. Molecular and Cellular Biology. 27(13). 4844–4862. 261 indexed citations
16.
Segura, Miguel F., Carme Solé, Marta Pascual, et al.. (2007). The Long Form of Fas Apoptotic Inhibitory Molecule Is Expressed Specifically in Neurons and Protects Them against Death Receptor-Triggered Apoptosis. Journal of Neuroscience. 27(42). 11228–11241. 65 indexed citations
17.
Delettre, Cécile, Vı́ctor J. Yuste, Rana S. Moubarak, et al.. (2005). AIFsh, a Novel Apoptosis-inducing Factor (AIF) Pro-apoptotic Isoform with Potential Pathological Relevance in Human Cancer. Journal of Biological Chemistry. 281(10). 6413–6427. 71 indexed citations
18.
Guergnon, Julien, Frédéric Dessauge, Victoria Domínguez Del Angel, et al.. (2005). Use of Penetrating Peptides Interacting with PP1/PP2A Proteins As a General Approach for a Drug Phosphatase Technology. Molecular Pharmacology. 69(4). 1115–1124. 46 indexed citations
19.
Thoulouze, Maria‐Isabel, Mireille Lafage, Vı́ctor J. Yuste, et al.. (2003). High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection. Virology. 314(2). 549–561. 26 indexed citations
20.
Thoulouze, Maria‐Isabel, Mireille Lafage, Vı́ctor J. Yuste, et al.. (2003). Apoptosis Inversely Correlates with Rabies Virus Neurotropism. Annals of the New York Academy of Sciences. 1010(1). 598–603. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bret M. Evers Breakdown of academic impact, for papers by Simone Kühnle Breakdown of academic impact, for papers by Salih Şanlıoğlu Breakdown of academic impact, for papers by Sharon Frase Breakdown of academic impact, for papers by Annette Bakker Breakdown of academic impact, for papers by Theodoros I. Roumeliotis Breakdown of academic impact, for papers by Gabriel Ichim Breakdown of academic impact, for papers by Annick You-Ten Breakdown of academic impact, for papers by Iva Klevernic Breakdown of academic impact, for papers by Sridar V. Chittur
Rankless by CCL
2026